MARLBOROUGH, Mass. /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City.

David Pierce, executive vice president and president, MedSurg and Susie Lisa, vice president, Investor Relations, will participate in a 60-minute roundtable discussion session with the host analyst beginning at approximately 9:30 a.m. EST.  A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

A replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investorsbeginning approximately one hour following the completion of the event.


CONTACTS

Media:        

Investors:

Kate Haranis             

Susie Lisa, CFA

508-683-6585 (office)            

508-683-5565 (office)

Media Relations                

Investor Relations

Boston Scientific Corporation        

Boston Scientific Corporation

Kate.Haranis@bsci.com              

BSXInvestorRelations@bsci.com